Neuronexus Technologies, Inc.
Ann Arbor, MI Doing business as Nuvectra Part of NEL Group, Inc.
- UEI
- D5WZFBNJE5Y3
- CAGE
- 37YY8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
DUGBMW9HZTL1
-
Parent
DUGBMW9HZTL1
- SAM.gov registration date
- Physical address
- 640 Avis Dr Suite 200, Ann Arbor, MI 48108, USA
- Website
- neuronexus.com
- Founded
- 2004
- Employees
- 11-50
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $24,097 |
| FY2025 | $24,205 |
| FY2024 | $0 |
| FY2023 | $269,542 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $24,097 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Purdue University | U01NS126052 | $282,123 | |
| Alcorix CO. | R42NS115282 | $405,048 | |
| Purdue University | U01NS126052 | $166,340 |
Similar vendors
About the company
Neuronexus Technologies, Inc., doing business as Nuvectra, manufactures electrophysiology recording systems, neural probes, microelectrodes, and data acquisition hardware for federal neuroscience research as a prime contractor (92% of recent awards) and a subsidiary of NEL Group, Inc. The company competes on full-and-open basis — no set-asides appear in the recent portfolio — and is based in Ann Arbor, Michigan, with secondary performance locations in Baltimore, Maryland. Primary NAICS alignment is Electromedical and Electrotherapeutic Apparatus Manufacturing (16 awards) and Surgical and Medical Instrument Manufacturing (6 awards); PSC coding runs to Laboratory Equipment And Supplies (20 awards) and Medical And Surgical Instruments, Equipment, And Supplies (6 awards).
Nuvectra's federal customer base concentrates heavily in the National Institutes of Health ecosystem. The top five funding agencies account for 66% of awards by count, led by NIDA (12 awards, $369 thousand combined potential value), the Department of Veterans Affairs Veterans Integrated Service Network 10 (7 awards, $205 thousand), the National Institute of Neurological Disorders and Stroke (6 awards, $18 thousand), and Veterans Integrated Service Network 21 (5 awards, $85 thousand). The potential-value rankings diverge materially: the Navy's Information Warfare Systems Command anchors the dollar position with a single $1.1 million award, while NIDA's smaller contract awards dominate by volume. Recent purchase orders include a $75 thousand X-DAQ ONE Series electrophysiology recording system (hardware, software, and silicon probes) to NIDA in August 2023, customization of software and hardware for rat-brain neural recording across multiple $25 thousand NIDA purchase orders in September 2023, a $24.2 thousand X-HEADSTAGE apparatus to the National Institute of Diabetes and Digestive and Kidney Diseases in September 2023, and a $25 thousand purchase order from NIDA for neural recording probes in September 2025.
Nuvectra operates as prime recipient on a Phase I SBIR grant from NIMH (award date March 1, 2025, $2.0 million potential value through February 2027) to develop an integrated culture and recording system for long-term electrophysiological profiling in human brain organoids, focusing on organoid assay chambers and 3D neural probes for extracellular recording and stimulation. The company also subcontracts under NIH-funded grants: subawards from Purdue University on electromicrostimulation research (November 2024) and on ultra-microelectrode array development and characterization (January 2024), and from Alcorix Co on thin-film interconnect and packaging design and validation (October 2024).
Activity has grown unevenly — one award in 2022, nine in 2023, four in 2024, two in 2025, and one in 2026 — with only two awards (combined potential value $24 thousand) reaching ultimate completion inside the next twenty-four months. The combined dollars obligated across the portfolio ($9.3 million) exceed the combined potential value ($2 million) by a factor of 4.62x, indicating substantial prior-year invoiced value and ongoing performance obligations that do not carry forward ceiling values into current reporting.
Quick answers
Is Neuronexus Technologies, Inc. registered in SAM.gov?
Yes. Neuronexus Technologies, Inc.'s SAM.gov registration is active through January 5, 2027.
How much has Neuronexus Technologies, Inc. received in federal contracts?
Federal contracts obligated $24,205 to Neuronexus Technologies, Inc. in fiscal year 2025 and $317,843 in fiscal years 2023 through 2027.
What is Neuronexus Technologies, Inc.'s most recent federal award?
Neuronexus Technologies, Inc.'s most recent federal contract award is Neuro nexus technologies, INC.:1178230 [26-000507] (75N95B26P00013), from National Institute of Mental Health (NIH), on January 20, 2026.
On GovTribe
See Neuronexus Technologies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors